TechCrunch spotlights 9 biotech startups from Startup Battlefield 200

Every year, Startup Battlefield—TechCrunch’s annual pitch contest—draws thousands of applicants. The competition narrows these applications down to 200 top contenders. From this cohort, the top 20 startups compete on the big stage for the Startup Battlefield Cup, which is the prize awarded to the winner of the pitch contest, and a $100,000 cash prize. The remaining 180 startups also participate in the competition, representing a wide range of sectors. Among this year’s cohort, nine biotech and pharmaceutical startups stood out for their applications of technology to healthcare and life sciences.

The selected startups include:

• CasNx: The company has developed an antivirus treatment for organs from organ donors. It uses a gene-editing technology (CRISPR) kit to eliminate viruses and install “universal donor” markers while the organ is being preserved outside the body.
• Chipiron: This startup is building a light and inexpensive, open full-body MRI machine to make MRI cancer diagnostics more widely available. The machine uses a superconducting quantum interference device; a highly sensitive magnetometer (SQUID) to measure weak magnetic fields.
• Exactics: The company is building a platform to create rapid diagnostic tests, starting with at-home screening for Lyme disease, with plans to expand to other illnesses.
• Lumos Strategies OÜ: The startup has created a consumer high-frequency electromagnetic device called Avara, which is designed to provide gentle, non-contact “inductive therapy” to improve sleep, relaxation, and exercise recovery.
• Miraqules: This company developed a nanotechnology in powder form that mimics blood-clotting proteins to provide instant blood clotting as an alternative to traditional wound treatments.
• Nephrogen: The startup is developing gene therapy solutions for kidney illnesses, using AI to target gene-editing to the exact cells in the kidney causing the illness.
• PraxisPro: This company provides an AI-powered training system for sales and marketing roles in life science industries, offering compliance-approved content, simulations, and real-time analytics.
• Reme-D: The startup is developing rapid diagnostic tests specifically geared toward underserved communities, designed to be affordable and stable in hot and humid climates.
• Surgicure Technologies: The company has created a patented solution to more safely and reliably secure endotracheal tubes—which are flexible tubes inserted through the mouth or nose during surgeries or other treatments—to make them safer and more comfortable for patients.

Why it matters

The Startup Battlefield 200 list serves as a barometer for emerging biotech and pharma trends, showcasing how startups are applying technologies like AI and gene-editing to solve specific medical and operational challenges.